Showing results (201-210 of 330) with videos related to
Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2003
Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trialKatja Ott, Ulrich Fink, Karen Becker, et al.BMC Cancer|August 20, 2015
Efficacy of a brief manualized intervention Managing Cancer and Living Meaningfully (CALM) adapted to German cancer care settings: study protocol for a randomized controlled trialKatharina Scheffold, Rebecca Philipp, Dorit Engelmann, et al.Oncology Research and Treatment|May 29, 2026
Safety and preliminary activity of neoadjuvant trastuzumab deruxtecan (T-DXd) plus 5-fluorouracil and folinic acid for HER2-positive, resectable esophagogastric adenocarcinoma: Results from the safety run-in cohort of the phase Ib/II UCCL-AIO-STO0124-IKF072 NeoART trialGertraud Stocker, Jack Chater, Thomas J Ettrich, et al.Nature Reviews. Disease Primers|December 17, 2021
Primary and metastatic peritoneal surface malignanciesDelia Cortés-Guiral, Martin Hübner, Mohammad Alyami, et al.BMC Cancer|March 24, 2012
A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trialAnne Katrin Berger, Carl von Gall, Ulrich Abel, et al.Cancer Medicine|August 1, 2025
Early Cancer Survivorship Distress Trajectories Associated With Socioeconomic Status and Age: Findings From a Multicenter Prospective StudyAnja Mehnert-Theuerkauf, Ute Goerling, Tanja Zimmermann, et al.European Journal of Cancer (Oxford, England : 1990)|November 24, 2019
Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancerAnna D Wagner, Florian Lordick, Heike I Grabsch, et al.European Journal of Cancer (Oxford, England : 1990)|December 2, 2025
Progression-free survival as a surrogate for overall survival in gastro-esophageal cancer trials with immunotherapy: A meta-analysisAlberto Giovanni Leone, Fausto Petrelli, Samuel J Klempner, et al.Journal of Cancer Research and Clinical Oncology|February 6, 2024
The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in patients with hepatocellular carcinomaAnne Olbrich, Johannes Niemeyer, Hendrik Seiffert, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2007
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysisKen Herrmann, Katja Ott, Andreas K Buck, et al.Pageof 33